PORIB presente en ISPOR con 2 Comunicaciones
▶️PORIB ha estado presente en el Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR), celebrado en Viena del 8... Read More
Comparaciones Indirectas en ETS
🔬 ¿Cómo comparar tratamientos cuando nunca se han enfrentado entre sí? En el ámbito de la Evaluación de Tecnologías Sanitarias (ETS/HTA), no... Read More
Grau S, Cantero H, Martín-Escudero V, González-Alonso del Hoyo R, Mareque M
Clinical and economic value of seladelpar in combination with ursodeoxycholic acid for the treatment of Primary Biliary Cholangitis in Spain
Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Viena. 8-10 nov 2026
POSTER
Robles-Plaza M, Prats C, Soriano-Arandes A, Antón A, de Pedro S, Oyagüez I, Capel Sanchez M, Rubín A; Sánchez G
Cost-effectiveness analysis of expanded influenza vaccination coverage with live attenuated influenza vaccine (LAIV) in children aged 2-11 years in Catalonia (Spain)
Annual European Congress International Society for Pharmacoeconomics & Outcomes Research (ISPOR). Viena. 8-10 nov 2026
POSTER